EE164 Cost-Effectiveness of Inclisiran as Add-on Therapy to Standard-of-Care for the Secondary Prevention of Cardiovascular Events in Patients with Elevated LDL Cholesterol

Saved in:
Bibliographic Details
Published in:Value in health 2023-12, Vol.26 (12), p.S82
Main Authors: Wong, M., Lim, J.Q.P., Tan, L.E., Abdul Aziz, M.I., Ong, S.K.B., Ng, K.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2023.09.433